Viewing Study NCT02201459


Ignite Creation Date: 2025-12-24 @ 2:49 PM
Ignite Modification Date: 2026-03-12 @ 10:43 AM
Study NCT ID: NCT02201459
Status: COMPLETED
Last Update Posted: 2025-10-02
First Post: 2014-06-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Nilotinib ± Peg-IFN for First Line Chronic Phase CML Patients
Sponsor: Hospices Civils de Lyon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module